Phase II Randomized Study of Plitidepsin (Aplidin), Alone or in Association with L-carnitine, in Patients with Unresectable Advanced Renal Cell Carcinoma

This randomized phase II study evaluated two schedules of the marine compound Plitidepsin with or without co-administration of L-carnitine in patients with renal cell carcinoma. Patients had adequate performance status and organ function. The primary endpoint was the rate of disease control (no prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Schöffski, Patrick, Guillem, Vincente, Garcia, Margarita, Rivera, Fernando, Tabernero, Josep, Cullell, Martin, Lopez-Martin, Jose Antonio, Pollard, Patricia, Dumez, Herlinde, del Muro, Xavier Garcia, Paz-Ares, Luis
Formato: Texto
Lenguaje:English
Publicado: Molecular Diversity Preservation International 2009
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666889/
https://www.ncbi.nlm.nih.gov/pubmed/19370171
http://dx.doi.org/10.3390/md7010057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666889/
https://www.ncbi.nlm.nih.gov/pubmed/19370171
http://dx.doi.org/10.3390/md7010057

Ejemplares similares